A New Project Seeks to Preserve Medication Abortion Stories as Legal Battles Continue
Abortion Access Front's Mife Stories Project aims to collect 1,000 anonymous accounts of medication abortion and miscarriage care, creating a lasting public archive.
As legal and political challenges to medication abortion continue, a coalition of abortion rights organizations is launching an effort to document the experiences of the people most directly affected. The Mife Stories Project, led by Abortion Access Front and several national partners, aims to collect 1,000 anonymous accounts from people who have used mifepristone for abortion or miscarriage management. Organizers hope the project will become both a resource for patients and journalists and a lasting archive that captures a pivotal moment in reproductive health care.
I recently spoke with Kristin Hady, programs director at Abortion Access Front, about why the organization decided now was the right time to launch the initiative.
“What we wanted to do was really flood the zone with positive, real, lived medication abortion stories,” Hady said. “Stories that take you beyond the junk science studies that are trying to be used to get mife- and abortion pills taken off the market.”
Hady said the project was born out of growing concern over continued legal attacks on medication abortion and the possibility that access to mifepristone could become even more restricted. Rather than allowing the public conversation to be driven primarily by lawsuits and political rhetoric, organizers wanted to elevate the experiences of people who have actually used the medication.
“It humanizes an issue that we often forget is connected to real people,” Hady said.
The timing is intentional. With medication abortion remaining at the center of ongoing litigation and regulatory debates, Hady said organizers believe personal narratives can help remind policymakers and the public that every legal decision affects real people making deeply personal medical decisions. She also noted that telehealth has dramatically changed abortion access since the Supreme Court overturned Roe v. Wade. As clinics have closed across many states, more patients have turned to medication abortion by mail, making accurate public understanding of the medications even more important.
A central concern throughout the project has been protecting participants’ privacy. Hady explained that organizers deliberately collect as little identifying information as possible. They do not retain names, email addresses or IP addresses, and contributors are encouraged to avoid including details that could identify themselves or their health care providers. Every submission is reviewed before publication, with edits limited primarily to grammar and removing any potentially identifying information. The goal, she said, is to make participation as safe as possible for people who may live in states with restrictive abortion laws.
One of the most striking parts of the conversation centered on the diversity of experiences the project has already received. Hady emphasized that there is no single abortion story. Some submissions come from people ending unintended pregnancies, while others describe using mifepristone during miscarriage management. Some recount pregnancies complicated by serious fetal diagnoses or abusive relationships, while others come from people who simply knew they were not ready—or did not want—to become parents. The emotional responses vary just as widely. Some writers describe grief, others relief, and many express a complicated mix of emotions.
Reading through hundreds of submissions, Hady said one theme surprised her more than any other: empowerment. Many contributors described feeling that making the decision themselves allowed them to shape their own futures and exercise control over their own lives. Others framed the decision as an act of compassion toward children they already had or toward pregnancies that could not survive. She said those stories reinforced the importance of recognizing that every abortion experience is different and that reducing them to a single narrative fails to capture reality.
The project also challenges common misconceptions about medication abortion. Hady said one of the most persistent myths is that abortion pills are inherently dangerous. She argued that decades of research have demonstrated their safety and effectiveness, while misinformation continues to discourage some patients from seeking care. She also believes many people overestimate how physically traumatic the process is because public discussion often focuses exclusively on the most difficult experiences.
“When they chip away at the public perception of safety, it’s going to keep people away from accessing the abortion pills,” Hady said.
Although the project is being launched amid ongoing legal battles, organizers hope it will remain valuable long after those cases are resolved. Hady envisions the website becoming an enduring public resource where patients can read about others’ experiences, journalists can better understand the range of medication abortion stories, advocates can educate policymakers, and researchers can study how abortion care evolved during this period. Rather than disappearing once the current campaign concludes, she expects the archive to continue growing as additional stories are submitted.
Among the submissions already received are stories from people who once opposed abortion rights until they themselves needed medication abortion or miscarriage care. Hady said those accounts illustrate how perspectives can change when reproductive health decisions become deeply personal, underscoring the importance of preserving a wide range of experiences rather than limiting the conversation to a handful of familiar narratives.
Ultimately, Hady hopes the project encourages people to spend time reading stories that are often absent from public debate. She believes the collection demonstrates not only the diversity of abortion experiences, but also the humanity behind them. At a time when medication abortion continues to be debated in courts and legislatures, she argues that those lived experiences deserve a place alongside the legal arguments and scientific evidence.
“We’re really proud of this,” Hady said, “and I would genuinely just encourage people to read the stories because there’s something so human and vulnerable about them, and it really gets to you in a good way.”



This is exactly why personal stories matter.
Medication abortion isn’t an abstract legal issue. It’s healthcare that millions of women have relied on safely and privately. Every lawsuit, every regulation, and every political attack has consequences for real women making deeply personal medical decisions.
Telehealth has become a lifeline as clinics have closed and states have erected barrier after barrier. We’ve seen that firsthand at Her Safe Harbor. Women aren’t choosing telehealth because it’s trendy—they’re choosing it because it’s often the safest, most practical, or the only accessible option.
But stories alone aren’t enough. They have to be paired with facts. Medication abortion is one of the most extensively studied medications in modern medicine, and women deserve evidence-based information—not fear campaigns or political misinformation.
When policymakers debate access, they aren’t debating a hypothetical. They’re deciding whether women will be able to receive timely, compassionate medical care when they need it most.